90 related articles for article (PubMed ID: 8154346)
1. Design of novel types of thrombin inhibitors based on modified D-Phe-Pro-Arg sequences.
Claeson G; Elgendy S; Cheng L; Chino N; Goodwin CA; Scully MF; Deadman J
Adv Exp Med Biol; 1993; 340():83-9. PubMed ID: 8154346
[No Abstract] [Full Text] [Related]
2. X-ray crystal structures of thrombin in complex with D-Phe-Pro-Arg and with small benzamidine- and arginine-based "non-peptidic" inhibitors.
Bode W
Adv Exp Med Biol; 1993; 340():15-26. PubMed ID: 8154332
[No Abstract] [Full Text] [Related]
3. Structure-based understanding of ligand affinity using human thrombin as a model system.
Nienaber VL; Mersinger LJ; Kettner CA
Biochemistry; 1996 Jul; 35(30):9690-9. PubMed ID: 8703940
[TBL] [Abstract][Full Text] [Related]
4. 1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
Harmat NJ; Di Bugno C; Criscuoli M; Giorgi R; Lippi A; Martinelli A; Monti S; Subissi A
Bioorg Med Chem Lett; 1998 May; 8(10):1249-54. PubMed ID: 9871744
[TBL] [Abstract][Full Text] [Related]
5. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
[TBL] [Abstract][Full Text] [Related]
6. Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors.
Figueiredo AC; Clement CC; Zakia S; Gingold J; Philipp M; Pereira PJ
PLoS One; 2012; 7(3):e34354. PubMed ID: 22457833
[TBL] [Abstract][Full Text] [Related]
7. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic determination of thrombin complexes with small synthetic inhibitors as a starting point for the receptor-based design of antithrombotics.
Bauer M; Brandstetter H; Turk D; Stürzebecher J; Bode W
Semin Thromb Hemost; 1993; 19(4):352-60. PubMed ID: 8140427
[No Abstract] [Full Text] [Related]
9. The rational design of thrombin-directed antithrombotics.
Fenton JW; Ni F; Witting JI; Brezniak DV; Andersen TT; Malik AB
Adv Exp Med Biol; 1993; 340():1-13. PubMed ID: 8154327
[No Abstract] [Full Text] [Related]
10. Inhibitor binding to thrombin: x-ray crystallographic studies.
Banner DW; Hadváry P
Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
[No Abstract] [Full Text] [Related]
11. Structure-based design and synthesis of novel thrombin inhibitors based on phosphinic peptide mimetics.
Li M; Lin Z; Johnson ME
Bioorg Med Chem Lett; 1999 Jul; 9(14):1957-62. PubMed ID: 10450962
[TBL] [Abstract][Full Text] [Related]
12. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity.
De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ
Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and comparison of tripeptidylfluoroalkane thrombin inhibitors.
Neises B; Broersma RJ; Tarnus C; Piriou F; Remy JM; Lintz C; Heminger EF; Kutcher LW
Bioorg Med Chem; 1995 Aug; 3(8):1049-61. PubMed ID: 7582979
[TBL] [Abstract][Full Text] [Related]
14. A novel molecular design of thrombin receptor antagonist.
Fujita T; Nakajima M; Inoue Y; Nose T; Shimohigashi Y
Bioorg Med Chem Lett; 1999 May; 9(10):1351-6. PubMed ID: 10360734
[TBL] [Abstract][Full Text] [Related]
15. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
[TBL] [Abstract][Full Text] [Related]
16. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
17. Conformationally restricted analogs of the direct thrombin inhibitor FM 19.
Girnys EA; Porter VR; Mosberg HI
Bioorg Med Chem; 2011 Dec; 19(24):7425-34. PubMed ID: 22055408
[TBL] [Abstract][Full Text] [Related]
18. D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety.
Lange UE; Baucke D; Hornberger W; Mack H; Seitz W; Höffken HW
Bioorg Med Chem Lett; 2003 Jun; 13(12):2029-33. PubMed ID: 12781189
[TBL] [Abstract][Full Text] [Related]
19. Exploring the chiral space within the active site of alpha-thrombin with a constrained mimic of D-Phe-Pro-Arg--design, synthesis, inhibitory activity, and X-ray structure of an enzyme-inhibitor complex.
Hanessian S; Balaux E; Musil D; Olsson LL; Nilsson I
Bioorg Med Chem Lett; 2000 Feb; 10(3):243-7. PubMed ID: 10698445
[TBL] [Abstract][Full Text] [Related]
20. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
